A recombinant vaccine is a vaccine produced through recombinant DNA technology. This involves inserting the DNA encoding an antigen (such as a bacterial surface protein) that stimulates an immune response into bacterial or mammalian cells, expressing the antigen in these cells and then purifying it from them.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Recombinant Vaccines industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Market Segment by Product Application
Recombinant Human Vaccines
Animal Recombinant Vaccines
Finally, the report provides detailed profile and data information analysis of leading company.
Merck & Co., Inc
Green Cross Corporation
Pfizer Inc.
Bayer AG
Sanofi S A.
Protein Science Corporation
GlaxoSmithKline Plc.
Novartis AG
Bharat Biotech
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Recombinant Vaccines consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Recombinant Vaccines market by identifying its various subsegments.
3.Focuses on the key global Recombinant Vaccines manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Recombinant Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Recombinant Vaccines submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Recombinant Vaccines Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Recombinant Vaccines Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Recombinant Vaccines Segment by Type
2.1.1 Subunit Recombinant Vaccines
2.1.2 Attenuated Recombinant Vaccines
2.1.3 Vector Recombinant Vaccines
2.2 Market Analysis by Application
2.2.1 Recombinant Human Vaccines
2.2.2 Animal Recombinant Vaccines
2.3 Global Recombinant Vaccines Market Comparison by Regions (2017-2027)
2.3.1 Global Recombinant Vaccines Market Size (2017-2027)
2.3.2 North America Recombinant Vaccines Status and Prospect (2017-2027)
2.3.3 Europe Recombinant Vaccines Status and Prospect (2017-2027)
2.3.4 China Recombinant Vaccines Status and Prospect (2017-2027)
2.3.5 Japan Recombinant Vaccines Status and Prospect (2017-2027)
2.3.6 Southeast Asia Recombinant Vaccines Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Recombinant Vaccines Industry Impact
2.5.1 Recombinant Vaccines Business Impact Assessment - Covid-19
2.5.2 Market Trends and Recombinant Vaccines Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Recombinant Vaccines Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Recombinant Vaccines Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Recombinant Vaccines Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Recombinant Vaccines Manufacturer Market Share
3.5 Top 10 Recombinant Vaccines Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Recombinant Vaccines Market
3.7 Key Manufacturers Recombinant Vaccines Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Recombinant Vaccines Industry Key Manufacturers
4.1 Merck & Co., Inc
4.1.1 Compan Detail
4.1.2 Merck & Co., Inc Recombinant Vaccines Product Introduction, Application and Specification
4.1.3 Merck & Co., Inc 138 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Merck & Co., Inc News
4.2 Green Cross Corporation
4.2.1 Compan Detail
4.2.2 Green Cross Corporation Recombinant Vaccines Product Introduction, Application and Specification
4.2.3 Green Cross Corporation Recombinant Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Merck & Co., Inc News
4.3 Pfizer Inc.
4.3.1 Compan Detail
4.3.2 Pfizer Inc. Recombinant Vaccines Product Introduction, Application and Specification
4.3.3 Pfizer Inc. Recombinant Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Pfizer Inc. News
4.4 Bayer AG
4.4.1 Compan Detail
4.4.2 Bayer AG Recombinant Vaccines Product Introduction, Application and Specification
4.4.3 Bayer AG Recombinant Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Bayer AG News
4.5 Sanofi S A.
4.5.1 Compan Detail
4.5.2 Bayer AG Recombinant Vaccines Product Introduction, Application and Specification
4.5.3 Sanofi S A. Recombinant Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Sanofi S A. News
4.6 Protein Science Corporation
4.6.1 Compan Detail
4.6.2 Protein Science Corporation Recombinant Vaccines Product Introduction, Application and Specification
4.6.3 Protein Science Corporation Recombinant Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Protein Science Corporation News
4.7 GlaxoSmithKline Plc.
4.7.1 Compan Detail
4.7.2 GlaxoSmithKline Plc. Recombinant Vaccines Product Introduction, Application and Specification
4.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Novartis AG
4.8.1 Compan Detail
4.8.2 Novartis AG Recombinant Vaccines Product Introduction, Application and Specification
4.8.3 Novartis AG Recombinant Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Novartis AG News
4.9 Bharat Biotech
4.9.1 Compan Detail
4.9.2 Bharat Biotech Recombinant Vaccines Product Introduction, Application and Specification
4.9.3 Bharat Biotech Recombinant Vaccines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Bharat Biotech News
5 Global Recombinant Vaccines Market Segment by Big Type
5.1 Global Recombinant Vaccines Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Recombinant Vaccines Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Recombinant Vaccines Revenue and Market Share by Big Type (2017-2022)
5.2 Subunit Recombinant Vaccines Sales Growth Rate and Price
5.2.1 Global Subunit Recombinant Vaccines Sales Growth Rate (2017-2022)
5.2.2 Global Subunit Recombinant Vaccines Price (2017-2022)
5.3 Attenuated Recombinant Vaccines Sales Growth Rate and Price
5.3.1 Global Attenuated Recombinant Vaccines Sales Growth Rate (2017-2022)
5.3.2 Global Attenuated Recombinant Vaccines Price (2017-2022)
5.4 Vector Recombinant Vaccines Sales Growth Rate and Price
5.4.1 Global Vector Recombinant Vaccines Sales Growth Rate (2017-2022)
5.4.2 Global Vector Recombinant Vaccines Price (2017-2022)
6 Global Recombinant Vaccines Market Segment by Big Application
6.1 Global Recombinant Vaccines Sales Market Share by Big Application (2017-2022)
6.2 Recombinant Human Vaccines Sales Growth Rate (2017-2022)
6.3 Animal Recombinant Vaccines Sales Growth Rate (2017-2022)
7 Global Recombinant Vaccines Forecast
7.1 Global Recombinant Vaccines Revenue, Sales and Growth Rate (2022-2027)
7.2 Recombinant Vaccines Market Forecast by Regions (2022-2027)
7.2.1 North America Recombinant Vaccines Market Forecast (2022-2027)
7.2.2 Europe Recombinant Vaccines Market Forecast (2022-2027)
7.2.3 China Recombinant Vaccines Market Forecast (2022-2027)
7.2.4 Japan Recombinant Vaccines Market Forecast (2022-2027)
7.2.5 Southeast Asia Recombinant Vaccines Market Forecast (2022-2027)
7.2.6 Other Regions Recombinant Vaccines Market Forecast (2022-2027)
7.3 Recombinant Vaccines Market Forecast by Type (2022-2027)
7.3.1 Global Recombinant Vaccines Sales Forecast by Type (2022-2027)
7.3.2 Global Recombinant Vaccines Market Share Forecast by Type (2022-2027)
7.4 Recombinant Vaccines Market Forecast by Application (2022-2027)
7.4.1 Global Recombinant Vaccines Sales Forecast by Application (2022-2027)
7.4.2 Global Recombinant Vaccines Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Recombinant Vaccines Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Recombinant Vaccines Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Recombinant Vaccines
Figure Market Concentration Ratio and Market Maturity Analysis of Recombinant Vaccines
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Recombinant Vaccines Market Size by Big Type
Figure Global Market Share of Recombinant Vaccines by Big Type in 2021
Figure Subunit Recombinant Vaccines Picture (2017-2022)
Figure Attenuated Recombinant Vaccines Picture (2017-2022)
Global Recombinant Vaccines Market Size by Big Application
Table Global Recombinant Vaccines Market Size by Application
Figure Global Recombinant Vaccines Market Share by Big Application in 2021
Figure Recombinant Human Vaccines Picture
Figure Animal Recombinant Vaccines Picture
Table Global Recombinant Vaccines Comparison by Regions (M USD) (2017-2027)
Figure Global Recombinant Vaccines Market Size (Million US$) (2017-2027)
Figure North America Recombinant Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Recombinant Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Figure China Recombinant Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Recombinant Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Recombinant Vaccines Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Recombinant Vaccines Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Recombinant Vaccines Sales by Manufacturer (2017-2022)
Figure Global Recombinant Vaccines Sales Market Share by Manufacturer in 2021
Table Global Recombinant Vaccines Revenue by Manufacturer (2017-2022)
Figure Global Recombinant Vaccines Revenue Market Share by Manufacturer in 2021
Table Global Recombinant Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Recombinant Vaccines Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Recombinant Vaccines Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Recombinant Vaccines Market
Table Key Manufacturers Recombinant Vaccines Product Type
Table Mergers & Acquisitions Planning
Table Merck & Co., Inc Company Profile
Table Recombinant Vaccines Product Introduction, Application and Specification of Merck & Co., Inc
Table Recombinant Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Green Cross Corporation Company Profile
Table Recombinant Vaccines Product Introduction, Application and Specification of Green Cross Corporation
Table Recombinant Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Green Cross Corporation Recent Development
Table Pfizer Inc. Company Profile
Table Recombinant Vaccines Product Introduction, Application and Specification of Pfizer Inc.
Table Recombinant Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Inc. Main Business
Table Pfizer Inc. Recent Development
Table Bayer AG Company Profile
Table Recombinant Vaccines Product Introduction, Application and Specification of Bayer AG
Table Recombinant Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer AG Main Business
Table Bayer AG Recent Development
Table Bayer AG Main Business
Table Bayer AG Recent Development
Table Sanofi S A. Company Profile
Table Recombinant Vaccines Product Introduction, Application and Specification of Sanofi S A.
Table Recombinant Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi S A. Main Business
Table Sanofi S A. Recent Development
Table Protein Science Corporation Company Profile
Table Recombinant Vaccines Product Introduction, Application and Specification of Protein Science Corporation
Table Recombinant Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Protein Science Corporation Main Business
Table Protein Science Corporation Recent Development
Table GlaxoSmithKline Plc. Company Profile
Table Recombinant Vaccines Product Introduction, Application and Specification of GlaxoSmithKline Plc.
Table Recombinant Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GlaxoSmithKline Plc. Main Business
Table GlaxoSmithKline Plc. Recent Development
Table Novartis AG Company Profile
Table Recombinant Vaccines Product Introduction, Application and Specification of Novartis AG
Table Recombinant Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Bharat Biotech Company Profile
Table Recombinant Vaccines Product Introduction, Application and Specification of Bharat Biotech
Table Recombinant Vaccines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bharat Biotech Main Business
Table Bharat Biotech Recent Development
Figure Global Recombinant Vaccines Sales and Growth Rate (2017-2022)
Figure Global Recombinant Vaccines Revenue and Growth Rate (2017-2022)
Table Global Recombinant Vaccines Sales by Regions (2017-2022)
Figure Global Recombinant Vaccines Sales Market Share by Regions in 2021
Table Global Recombinant Vaccines Revenue by Regions (2017-2022)
Figure Global Recombinant Vaccines Revenue Market Share by Regions in 2021
Figure North America Recombinant Vaccines Sales and Growth Rate (2017-2022)
Figure Europe Recombinant Vaccines Sales and Growth Rate (2017-2022)
Figure China Recombinant Vaccines Sales and Growth Rate (2017-2022)
Figure Japan Recombinant Vaccines Sales and Growth Rate (2017-2022)
Figure Southeast Asia Recombinant Vaccines Sales and Growth Rate (2017-2022)
Figure Other Regions Recombinant Vaccines Sales and Growth Rate (2017-2022)
Table Global Recombinant Vaccines Sales by Big Type (2017-2022)
Table Global Recombinant Vaccines Sales Market Share by Big Type (2017-2022)
Figure Global Recombinant Vaccines Sales Market Share by Big Type in 2019
Table Global Recombinant Vaccines Revenue by Big Type (2017-2022)
Table Global Recombinant Vaccines Revenue Market Share by Big Type (2017-2022)
Table Global Recombinant Vaccines Revenue Market Share by Big Type in 2019
Figure Global Subunit Recombinant Vaccines Sales Growth Rate (2017-2022)
Figure Global Subunit Recombinant Vaccines Price (2017-2022)
Figure Global Attenuated Recombinant Vaccines Sales Growth Rate (2017-2022)
Figure Global Attenuated Recombinant Vaccines Price (2017-2022)
Figure Global Vector Recombinant Vaccines Sales Growth Rate (2017-2022)
Table Global Recombinant Vaccines Sales by Big Application (2017-2022)
Table Global Recombinant Vaccines Sales Market Share by Big Application (2017-2022)
Figure Global Recombinant Vaccines Sales Market Share by Big Application in 2019
Figure Global Recombinant Human Vaccines Sales Growth Rate (2017-2022)
Figure Global Animal Recombinant Vaccines Sales Growth Rate (2017-2022)
Figure Global Recombinant Vaccines Sales and Growth Rate (2022-2027)
Figure Global Recombinant Vaccines Revenue and Growth Rate (2022-2027)
Table Global Recombinant Vaccines Sales Forecast by Regions (2022-2027)
Table Global Recombinant Vaccines Market Share Forecast by Regions (2022-2027)
Figure North America Sales Recombinant Vaccines Market Forecast (2022-2027)
Figure Europe Sales Recombinant Vaccines Market Forecast (2022-2027)
Figure China Sales Recombinant Vaccines Market Forecast (2022-2027)
Figure Japan Sales Recombinant Vaccines Market Forecast (2022-2027)
Figure Southeast Asia Sales Recombinant Vaccines Market Forecast (2022-2027)
Figure Other Regions Sales Recombinant Vaccines Market Forecast (2022-2027)
Table Global Recombinant Vaccines Sales Forecast by Type (2022-2027)
Table Global Recombinant Vaccines Market Share Forecast by Type (2022-2027)
Table Global Recombinant Vaccines Sales Forecast by Application (2022-2027)
Table Global Recombinant Vaccines Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Vaccines
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Recombinant Vaccines Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Recombinant Vaccines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Recombinant Vaccines Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Recombinant Vaccines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Recombinant Vaccines Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Recombinant Vaccines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Recombinant Vaccines Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Recombinant Vaccines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Merck & Co., Inc
Green Cross Corporation
Pfizer Inc.
Bayer AG
Sanofi S A.
Protein Science Corporation
GlaxoSmithKline Plc.
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)